Tracleer and hepatic function abnormal 
Tracleer and hepatic function abnormal Patient Reports February 11, 2012
Tracleer Side Effects Report #5252100-4
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on Feb 14, 2007. Female patient, 82 years of age, weighting 97.00 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiomyopathy , gamma-glutamyltransferase increased, hepatic function abnormal. Tracleer dosage: 62.5 MG, QD, ORAL. During the same period patient was treated with NIFEDIPINE, VALSARTAN, BISOPROLOL FUMARATE, FERROUS CITRATE, ASPIRIN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5168313-6
Tracleer side effect was reported by a Physician from JAPAN on Nov 16, 2006. Female patient, 82 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, condition aggravated, hepatic function abnormal, multi-organ failure, off label use, pulmonary hypertension . Tracleer dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with EPOPROSTENOL, BERAPROST, FUROSEMIDE, OXYGEN. Patient died on 12/27/2005.Tracleer Side Effects Report #5192513-2
Tracleer side effect was reported by a Physician from JAPAN on Dec 04, 2006. Female patient, 76 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal. Tracleer dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with BERAPROST, SARPOGRELATE HYDROCHLORIDE, ASPIRIN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #4943827-X
Tracleer side effect was reported by a Physician from JAPAN on Feb 24, 2006. Female patient, 76 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic function abnormal, malaise, nausea . Tracleer dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, FUROSEMIDE, WARFARIN, BERAPROST, OXYGEN, SILDENAFIL, MEXILETINE HYDROCHLORIDE. Patient recovered.Tracleer Side Effects Report #4960340-4
Tracleer side effect was reported by a Physician from JAPAN on Mar 12, 2006. Female patient, 76 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic function abnormal, malaise, nausea . Tracleer dosage: 125 MG, BID, ORAL; SEE IMAGE. During the same period patient was treated with SPIRONOLACTONE, FUROSEMIDE, WARFARIN, MEXILETINE, BERAPROST, OXYGEN, SILDENAFIL. Patient recovered.Tracleer Side Effects Report #5115331-X
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on Sept 08, 2006. Male patient, 74 years of age, weighting 121.3 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, platelet count decreased. Tracleer dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with BERAPROST, WARFARIN, BARNIDIPINE, ENALAPRIL MALEATE, URSODIOL, OXYGEN, ALLOPURINOL. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5122822-4
Tracleer side effect was reported by a Physician from JAPAN on Sept 19, 2006. Male patient, 74 years of age, weighting 121.3 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased appetite, fatigue, hepatic function abnormal, platelet count decreased. Tracleer dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with BERAPROST, WARFARIN, BARNIDIPINE, ENALAPRIL MALEATE, URSODIOL, OXYGEN, ALLOPURINOL. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5154578-3
Tracleer side effect was reported by a Physician from JAPAN on Oct 27, 2006. Male patient, 74 years of age, weighting 121.3 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased appetite, fatigue, hepatic function abnormal, platelet count decreased. Tracleer dosage: 62.5 MG, BID; ORAL. During the same period patient was treated with BERAPROST, WARFARIN, BARNIDIPINE, ENALAPRIL MALEATE, URSODEOXYCHOLIC ACID, OXYGEN, ALLOPURINOL. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5285260-X
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on Mar 14, 2007. Female patient, 72 years of age, weighting 112.4 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, brain natriuretic peptide increased, cardiac failure, condition aggravated, hepatic function abnormal, interstitial lung disease, pulmonary hypertension . Tracleer dosage: unknown. During the same period patient was treated with BERAPROST, WARFARIN, FUROSEMIDE, LOSARTAN POSTASSIUM. Patient died on 10/23/2005.Tracleer Side Effects Report #5371914-3
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on June 11, 2007. Male patient, 71 years of age, weighting 83.78 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Tracleer dosage: 62.5 MG, QD, ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, BERAPROST, ETODOLAC. Patient died on 02/18/2007.Tracleer Side Effects Report #5397272-6
Tracleer side effect was reported by a Physician from JAPAN on July 06, 2007. Male patient, 71 years of age, weighting 83.78 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cardiac arrest , condition aggravated, hepatic function abnormal, loss of consciousness. Tracleer dosage: 62.5 MG, QD, ORAL; 62.5 MG, BID, ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, BERAPROST, ETODOLAC, AZOSEMIDE. Patient died on 02/18/2007.Tracleer Side Effects Report #5664090-0
Tracleer side effect was reported by a Physician from UNITED STATES on Feb 26, 2008. Female patient, 71 years of age, weighting 127.9 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, fatigue, hepatic enzyme increased, hepatic function abnormal, jaundice , pulmonary hypertension , red blood cell count decreased. Tracleer dosage: 125 MG, BID, ORAL; 62.5 MG, BID, ORAL; 62.5 MG. During the same period patient was treated with LEVOXYL, NEXIUM, POTASSIUM CHLORIDE, TRAZODONE, OXYBUTYNIN, CYMBALTA. Patient died on 02/02/2008.Tracleer Side Effects Report #5009192-7
Tracleer side effect was reported by a Health Professional from NETHERLANDS on May 05, 2006. Male patient, 71 years of age, weighting 145.5 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Tracleer dosage: 125 MG, BID, ORAL; 62.5 MG, BID, ORAL. During the same period patient was treated with MIRTAZAPINE, NEXIUM, SPIRONOLACTONE, FUROSEMIDE, FRISIUM. Patient recovered.Tracleer Side Effects Report #5016841-6
Tracleer side effect was reported by a Health Professional from NETHERLANDS on May 11, 2006. Male patient, 71 years of age, weighting 145.5 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Tracleer dosage: 125 MG, BID, ORAL; 62.5 MG, BID, ORAL. During the same period patient was treated with MIRTAZAPINE, NEXIUM, SPIRONOLACTONE, FUROSEMIDE, FRISIUM. Patient recovered.Tracleer Side Effects Report #5291442-3
Tracleer side effect was reported by a Physician from NETHERLANDS on Mar 22, 2007. Female patient, 70 years of age, weighting 116.8 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, hepatic function abnormal, liver function test abnormal. Tracleer dosage: unknown. During the same period patient was treated with PANTOZOL, FERROGRAD. Patient recovered.Tracleer Side Effects Report #4967431-2
Tracleer side effect was reported by a Physician from NETHERLANDS on Mar 22, 2006. Female patient, 70 years of age, weighting 116.8 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, hepatic function abnormal. Tracleer dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, FERROGRAD. Patient recovered.Tracleer Side Effects Report #5291441-1
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on Mar 19, 2007. Female patient, 63 years of age, weighting 101.4 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Tracleer dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with ALFACALCIDOL, FUROSEMIDE, VITAMIN B, PREDNISOLONE, FAMOTIDINE, RISEDRONATE, ATORVASTATIN CALCIUM, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #6009109-2
Tracleer side effect was reported by a Physician from JAPAN on Dec 01, 2008. Female patient, 62 years of age, weighting 97.00 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic congestion, hepatic function abnormal, oedema, oedema peripheral, pleural effusion, polyarthritis. Tracleer dosage: 125 MG, BID, ORAL; 62.5 MG, BID, ORAL. During the same period patient was treated with LANSOPRAZOLE, MAGNESIUM OXIDE, PREDNISOLONE, ALENDRONATE, ETHYL ICOSAPENTATE, FUROSEMIDE, SPIRONOLACTONE, CARDVEDIOL. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #6036497-3
Tracleer side effect was reported by a Physician from JAPAN on Dec 25, 2008. Female patient, 62 years of age, weighting 97.00 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, haemoglobin decreased, hepatic congestion, hepatic function abnormal, oedema, oedema peripheral. Tracleer dosage: 125 MG BID ORAL62.5 MG BID ORAL. During the same period patient was treated with LANSOPRAZOLE, MAGNESIUM OXIDE, PREDNISOLONE, ALENDRONATE, ETHYL ICOSAPENTATE, FUROSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #6103532-3
Tracleer side effect was reported by a Physician from JAPAN on Feb 19, 2009. Female patient, 61 years of age, weighting 105.8 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic function abnormal, off label use. Tracleer dosage: unknown. During the same period patient was treated with WARFARIN POTASSIUM, TORSEMIDE, AZELNIDIPINE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5849685-3
Tracleer side effect was reported by a Physician from JAPAN on Aug 06, 2008. Female patient, 60 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Tracleer dosage: 62.5 MG BID ORAL. During the same period patient was treated with WARFARIN POTASSIUM, FUROSEMIDE. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5252098-9
Tracleer side effect was reported by a Physician from JAPAN on Feb 14, 2007. Female patient, 58 years of age, weighting 92.59 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic function abnormal, international normalised ratio increased, platelet count decreased. Tracleer dosage: 125 MG, BID, ORAL, 62.5 MG, BID, ORAL. During the same period patient was treated with WARFARIN, OXYGEN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5078460-5
Tracleer side effect was reported by a Physician from JAPAN on July 25, 2006. Female patient, 58 years of age, weighting 92.59 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic function abnormal, international normalised ratio increased, platelet count decreased, prothrombin time prolonged. Tracleer dosage: unknown. During the same period patient was treated with WARFARIN, OXYGEN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #4996289-0
Tracleer side effect was reported by a Physician from JAPAN on Apr 25, 2006. Female patient, 58 years of age, weighting 92.59 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic function abnormal. Tracleer dosage: unknown. During the same period patient was treated with WARFARIN, OXYGEN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #4817585-3
Tracleer side effect was reported by a Physician from JAPAN on Oct 17, 2005. Female patient, 54 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal. Tracleer dosage: unknown. During the same period patient was treated with LIVER HYDROLYSIS COMBINATION, FUROSEMIDE. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #4919959-9
Tracleer side effect was reported by a Physician from JAPAN on Feb 01, 2006. Female patient, 54 years of age, weighting 119.0 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Tracleer dosage: unknown. During the same period patient was treated with LIVER HYDROLYSIS COMBINATION, FUROSEMIDE, BERAPROST, OXYGEN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #4883088-3
Tracleer side effect was reported by a Physician from JAPAN on Dec 27, 2005. Female patient, 53 years of age, weighting 129.4 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal. Tracleer dosage: 62.5 MG, QD, ORAL. During the same period patient was treated with BERAPROST. Patient recovered.Tracleer Side Effects Report #5353089-X
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on May 25, 2007. Female patient, 51 years of age, weighting 97.00 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, altered state of consciousness, aspartate aminotransferase increased, chest pain , condition aggravated, depressive symptom, hepatic function abnormal, pulmonary hypertension . Tracleer dosage: unknown. During the same period patient was treated with WARFARIN, CLOTIAZEPAMN, PAROXETINE, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5369174-2
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on June 06, 2007. Female patient, 51 years of age, weighting 97.00 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, altered state of consciousness, aspartate aminotransferase increased, chest pain , condition aggravated, depressive symptom, hepatic function abnormal, intentional overdose, pulmonary hypertension . Tracleer dosage: unknown. During the same period patient was treated with WARFARIN, CLOTIAZEPAM, PAROXETINE, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5931087-2
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on Oct 15, 2008. Female patient, 51 years of age, weighting 97.00 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, altered state of consciousness, aspartate aminotransferase increased, cardiac failure, chest pain , depressive symptom, disease progression, hepatic function abnormal, intentional overdose. Tracleer dosage: 125 MG, BID, ORAL; 62.5 MG, BID, ORAL; 62.5 MG, QD, ORAL; 125 MG, BID, ORAL. During the same period patient was treated with WARFARIN POTASSIUM, CLOTIAZEPAM, PAROXETINE, FLUNITRAZEPAM. Patient was hospitalized. Patient died.Tracleer Side Effects Report #5069559-8
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on July 19, 2006. Female patient, 50 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, hepatic function abnormal. Tracleer dosage: 62.5 MG BID ORAL. Patient recovered.Tracleer Side Effects Report #5166491-6
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on Nov 14, 2006. Female patient, 48 years of age, weighting 94.80 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Tracleer dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with METHYLPREDNISOLONE, FAMOTIDINE, FUROSEMIDE, ALFACALCIDOL, SULFAMETHOXAZOLE, LANSOPRAZOLE, OXYGEN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5220981-6
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on Jan 10, 2007. Female patient, 47 years of age, weighting 116.8 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, condition aggravated, disease progression, hepatic congestion, hepatic function abnormal, pulmonary hypertension . Tracleer dosage: 31.25 MG, BID, ORAL; 62.5 MG, BID. During the same period patient was treated with FERROUS CITRATE, EPOPROSTENOL, BERAPROST, WAFARIN POTASSIUM, OXYGEN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5081966-6
Tracleer side effect was reported by a Physician from JAPAN on Aug 01, 2006. Female patient, 45 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cardiac failure, condition aggravated, hepatic enzyme increased, hepatic function abnormal, liver disorder. Tracleer dosage: 125 MG, BID, ORAL; 31.25 MG, BID, ORAL; 62.5 MG, BID, ORAL; 62.5 MG, BID, ORAL. During the same period patient was treated with BERAPROST, FUROSEMIDE, WARFARIN, OXYGEN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5453543-6
Tracleer side effect was reported by a Physician from JAPAN on Aug 31, 2007. Female patient, 45 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, hepatic enzyme increased, hepatic function abnormal, right ventricular failure. Tracleer dosage: 125 MG, BID, ORAL; 31.25 MG, BID, ORAL; 62.5 MG, BID, ORAL. During the same period patient was treated with BERAPROST, FUROSEMIDE, WARFARIN, OXYGEN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5103070-0
Tracleer side effect was reported by a Physician from JAPAN on Aug 24, 2006. Female patient, 44 years of age, weighting 99.21 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, gastritis, hepatic function abnormal, nausea , platelet count decreased. Tracleer dosage: unknown. During the same period patient was treated with FAMOTIDINE, EPOPROSTENOL, LOPERAMIDE, FUROSEMIDE, SUCRALFATE. Patient recovered.Tracleer Side Effects Report #5113445-1
Tracleer side effect was reported by a Physician from JAPAN on Sept 06, 2006. Female patient, 44 years of age, weighting 99.21 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, gastritis, hepatic function abnormal, hypokalaemia, nausea , platelet count decreased, rash . Tracleer dosage: unknown. During the same period patient was treated with EPOPROSTENOL, LOPERAMIDE, FUROSEMIDE, LOXOPROFEN. Patient recovered.Tracleer Side Effects Report #5468297-7
Tracleer side effect was reported by a Health Professional from JAPAN on Sept 10, 2007. Female patient, 42 years of age, weighting 108.0 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, coagulation test abnormal, hepatic function abnormal. Tracleer dosage: 125 MG, BID, ORAL, 62.5 MG, BID, ORAL, 93.75 MG, BID, ORAL. During the same period patient was treated with WARFARIN POTASSIUM, BERAPROST, FERRIC PYROPHOSPHATE, THYROID PREPARATIONS, FUROSEMIDE. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5928856-1
Tracleer side effect was reported by a Health Professional from AUSTRALIA on Oct 09, 2008. Female patient, 42 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cellulitis , hepatic function abnormal, oedema peripheral, pyrexia, right ventricular failure. Tracleer dosage: 62.5 MG, BID, ORAL. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5048846-3
Tracleer side effect was reported by a Physician from JAPAN on June 23, 2006. Female patient, 39 years of age, weighting 114.6 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, catheter related infection, gamma-glutamyltransferase increased, hepatic function abnormal, liver disorder. Tracleer dosage: unknown. During the same period patient was treated with LEVOFLOXACIN. Patient recovered.Tracleer Side Effects Report #5078465-4
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on July 24, 2006. Female patient, 39 years of age, weighting 114.6 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chorioretinopathy, gamma-glutamyltransferase increased, hepatic function abnormal, liver disorder. Tracleer dosage: unknown. During the same period patient was treated with LEVOFLOXACIN. Patient recovered.Tracleer Side Effects Report #5278632-0
Tracleer side effect was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, 36 years of age, weighting 90.39 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, catheter site haemorrhage, haemoglobin decreased, headache , hepatic function abnormal, nausea . Tracleer dosage: unknown. During the same period patient was treated with FLOLAN, VIAGRA, SPIRONOLACTONE, PIMOBENDAN, RANITIDINE, TORSEMIDE, MOSAPRIDE. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5348373-X
Tracleer side effect was reported by a Physician from JAPAN on May 20, 2007. Female patient, 36 years of age, weighting 90.39 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, catheter site haemorrhage, haematoma, haemoglobin decreased, headache , hepatic function abnormal, nausea . Tracleer dosage: unknown. During the same period patient was treated with FLOLAN, VIAGRA, SPIRONOLACTONE, PIMOBENDAN, RANITIDINE, TORSEMIDE, MOSAPRIDE. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #4737011-2
Tracleer side effect was reported by a Physician from JAPAN on July 19, 2005. Female patient, 36 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, catheter site haemorrhage, haematoma, hepatic function abnormal, platelet count decreased, right ventricular failure. Tracleer dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with FLOLAN, VIAGRA, SPIRONOLACTONE, PIMOBENDAN, RANITIDINE, TORSEMIDE, MOSAPRIDE CITRATE, CIDEFERRON. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #4777550-1
Tracleer side effect was reported by a Physician from JAPAN on Aug 25, 2005. Female patient, 30 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, pyrexia. Tracleer dosage: unknown. During the same period patient was treated with PREDNISONE, BERAPROST, WARFARIN, FUROSEMIDE, CILEXETIL. Patient recovered.Tracleer Side Effects Report #5738399-6
Tracleer side effect was reported by a Physician from UNITED STATES on Apr 29, 2008. Male patient, 28 years of age, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: coagulopathy, continuous haemodiafiltration, disease progression, heart and lung transplant, hepatic congestion, hepatic function abnormal, hepatic ischaemia, international normalised ratio increased, intestinal ischaemia. Tracleer dosage: unknown. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient died on 04/12/2008.Tracleer Side Effects Report #5127933-5
Tracleer side effect was reported by a Consumer or non-health professional from JAPAN on Sept 22, 2006. Female patient, 25 years of age, weighting 138.9 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, decreased appetite, hepatic function abnormal, malaise. Tracleer dosage: unknown. During the same period patient was treated with RABAMIPIDE, SENNOSIDE. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5139730-5
Tracleer side effect was reported by a Physician from JAPAN on Oct 10, 2006. Female patient, 25 years of age, weighting 141.1 lb, was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, decreased appetite, dizziness , hepatic function abnormal, malaise, platelet count decreased. Tracleer dosage: unknown. During the same period patient was treated with REBAMIPIDE, SENNOSIDE, BERAPROST, OXYGEN. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #4692211-5
Tracleer side effect was reported by a Physician from on June 02, 2005. Female patient was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: ascites, condition aggravated, hepatic function abnormal, oedema. Tracleer dosage: unknown. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #4777458-1
Tracleer side effect was reported by a Physician from GERMANY on Sept 12, 2005. Female patient was diagnosed with pulmonary hypertension
and was treated with Tracleer. After drug was administered, patient experienced the following side effects: ascites, hepatic function abnormal, oedema. Tracleer dosage: unknown. Patient was hospitalized. Patient recovered.Tracleer Side Effects Report #5833496-9
Tracleer side effect was reported by a Physician from UNITED STATES on July 22, 2008. Female patient, 71 years of age, weighting 127.9 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dyspnoea, fatigue, hepatic failure, hepatic function abnormal, jaundice
. Tracleer dosage: 125 MG, BID, ORAL, 62.5 MG, BID, ORAL. During the same period patient was treated with LEVOXYL, NEXIUM, POTASSIUM CHLORIDE, TRAZODONE, OXYBUTYNIN, CYMBALTA. Patient died on 02/02/2008.Tracleer Side Effects Report #6111415-8
Tracleer side effect was reported by a Health Professional from JAPAN on Feb 27, 2009. Male patient, 17 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer. After drug was administered, patient experienced the following side effects: hepatic function abnormal, pulmonary alveolar haemorrhage. Tracleer dosage: unknown. During the same period patient was treated with EPOPROSTENOL. Patient recovered.
Tracleer Side Effects Report #5744900-9
Tracleer side effect was reported by a Physician from JAPAN on May 02, 2008. Female patient, 14 years of age, weighting 97.00 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, bradycardia, cardiac failure, cyanosis, hepatic congestion, hepatic function abnormal, hypoxia. Tracleer dosage: unknown. During the same period patient was treated with DIGOXIN, OXYGEN, PRAZOSIN, ALLOPURINOL. Patient recovered.
Tracleer Side Effects Report #5832536-0
Tracleer side effect was reported by a Physician from JAPAN on July 23, 2008. Female patient, 14 years of age, weighting 97.00 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, bradycardia, cardiac failure, cyanosis, hepatic congestion, hepatic function abnormal, hypoxia. Tracleer dosage: unknown. During the same period patient was treated with DIGOXIN, OXYGEN, PRAZOSIN GITS, ALLOPURINOL. Patient recovered.
Tracleer Side Effects Report #5832703-6
Tracleer side effect was reported by a Physician from JAPAN on July 23, 2008. Female patient, 14 years of age, weighting 97.00 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, bradycardia, cardiac failure, cyanosis, disease progression, hepatic function abnormal, pulmonary hypertension
. Tracleer dosage: 31.25 MG, BID, ORAL, 46.875 MG, BID, ORAL, 31.25 MG, BID, ORAL, 62.5 MG, BID, ORAL. During the same period patient was treated with DIGOXIN, OXYGEN, PRAZOSIN GITS, ALLOPURINOL. Patient recovered.Tracleer Side Effects Report #5041338-7
Tracleer side effect was reported by a Health Professional from NETHERLANDS on June 15, 2006. Female patient, 48 years of age, was treated with Tracleer. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Tracleer dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with SILDENAFIL CITRATE. Patient recovered.